I know this is blasphemous for an EM doc to say, but I’m actually pretty skeptical of high dose nitro having much of an effect for acute, cardiogenic pulmonary edema. I, too, have not intubated a SCAPE or decompensated heart failure patient in years, but I think it has very little to do with nitro and everything to do with NIPPV. I’ve lost count of the number of times I asked the nurse to bolus the patient 500mcg of nitro and start them at a rate of 100mcg/min and titrate down afterward, only to find the nurse never bolused the patient and started them at 5mcg/min (because that’s what the instructions on the bottle say) only to find the patient already looks significantly better just on BPAP and BP has already improved dramatically likely due to the patient feeling like they can breath again leading to a reduction in their sympathetic surge.
I have no evidence to back up my skepticism, but there is also no high quality data to back up the use of high dose nitro either. I still give it, but it’s just never as important to me as getting the patient on NIPPV. Honestly, I think it would be an interesting study to randomize SCAPE patients to standard cardene dosing vs high dose nitro therapy. I think the only problem with this study would be that you couldn’t blind the physicians to the therapies.
Very interesting topic! I've just done a deep dive on this.
There are multiple lines of evidence to support vasodilator therapy in acute decompensated heart failure, going back thirty years before NIV was commonly used or available. In fact, there was one prospective trial that compared NIV with vasodilator therapy directly and purported a benefit in favour of vasodilator therapy. Vasodilators even work wonders in frank cardiogenic shock. It's always fun to watch the nurses eyes when the MAP goes UP after starting sodium nitroprusside.
In other words, the evidence definitely supports the view that GTN works, even in the absence of NIV.
(Sorry for the copious references but I believe they are all the studies related to this question in particular. And it's meant in the academic spirit of the thread.)
Mullens Wilfried, Abrahams Zuheir, Francis Gary S., et al. Sodium nitroprusside for advanced low-output heart failure. Journal of the American College of Cardiology. 2008;52(3):200-207.
Nashed AH, Allegra JR. Intravenous nitroglycerin boluses in treating patients with cardiogenic pulmonary edema. Am J Emerg Med 1995;13(5):612–3 Sep.
Nashed A, Allegra JR, Eskin B, Garg S, Roche LM. Prospective trial of the treatment of acute cardiogenic pulmonary edema with intravenous nitroglycerine boluses. Ann Emerg Med 1997 Sep;30(3):382.
Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998;351(9100):389–93 Feb 7.
Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milovanov O, Polak R, et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 2000;36(3):832–7 Sep.